Jagosky, Megan H.
Usmani, Saad Z.
Article History
First Online: 20 March 2020
Compliance with Ethical Standards
:
: Megan H. Jagosky declares that she has no conflict of interest.Saad Z. Usmani has received consulting fees from Abbvie, Amgen, BMS, Celgene, EdoPharma, GSK, Janssen, Sanofi, Seattle Genetics, SkylineDx, Takeda, and TeneoBio; and research funding from Amgen, Array Biopharma, BMS, Celgene, Janssen, Pharmacyclics, Prothena, Sanofi, Seattle Genetics, SkylineDx, and Takeda.
: This article does not contain any studies with human or animal subjects performed by any of the authors.